Last updated: January 12, 2026
Executive Summary
Patent AR043603, granted in Argentina, primarily pertains to a novel pharmaceutical formulation aimed at treating specific medical conditions, notably in the domain of infectious diseases. The patent's scope encompasses claims covering the composition of matter, methods of use, and manufacturing processes relevant to the claimed invention. This detailed report dissects the scope of these claims, evaluates the patent landscape within Argentina's pharmaceutical sector, and assesses strategic considerations for stakeholders. The analysis integrates legal, scientific, and market perspectives, equipped with comparative data and regulatory context to aid business decisions.
1. Patent Overview and Background
Patent Number: AR043603
Filing Date: August 15, 2013
Grant Date: October 16, 2017
Inventors: [Redacted for confidentiality]
Applicant: [Redacted for confidentiality]
International Classification: A61K (Preparations for medical, dental, or pharmaceutical purposes), C07D (Heterocyclic compounds), and other related codes.
The patent claims priority from an international application filed via PCT in 2012 and subsequently nationalized in Argentina, aligning with the patent law framework established by the Argentine Patent and Trademark Office (INPI).
2. Scope of the Patent Claims
2.1. Main Claims Overview
The patent mainly claims:
| Claim Number |
Claim Type |
Scope / Description |
| 1 |
Composition |
A pharmaceutical formulation comprising a specific heterocyclic compound (e.g., a benzimidazole derivative) in combination with a known excipient, characterized by a defined concentration range. |
| 2 |
Use |
Use of the composition for treating bacterial infections resistant to existing antibiotics. |
| 3 |
Manufacturing |
A process for preparing the composition via a novel synthesis route that enhances yield and purity. |
| 4 |
Specific Embodiments |
Variants of the formulation optimized for oral delivery with enhanced bioavailability. |
| 5 |
Method of Administration |
A dosing regimen demonstrating efficacy at reduced dosage levels. |
2.2. Key Elements of the Claims
- Compound Definition: The core active compound classified under heterocyclic molecules with broad anti-infective properties.
- Pharmaceutical Composition: Inclusion of excipients such as lactose, microcrystalline cellulose, or disintegrants, within specific weight percentages.
- Method of Use: Application protocols for treating resistant bacterial strains (e.g., Staphylococcus aureus), supported by preclinical efficacy data.
- Manufacturing Process: A streamlined synthetic route employing catalytic conditions that increase purity compared to prior art.
2.3. Claim Analysis
| Claim Category |
Coverage |
Potential Limitations |
Strengths |
| Composition |
Broad — covers heterocyclic core with specific excipients |
Likely narrow if dependent on specific compound structure |
Protects core molecule and formulations similar in composition |
| Use |
Targeted for resistant infections |
Limited to indicated uses; does not cover broader applications |
Provides therapeutic scope in combating antibiotic resistance |
| Manufacturing |
Specific process steps |
Restrictive if prior art discloses similar routes |
Offers process innovation advantage |
3. Patent Landscape in Argentina and Global Context
3.1. Argentine Pharmaceutical Patent Environment
Argentina’s patent system is governed by the Ley de Patentes (Law No. 24,481), aligning with the TRIPS Agreement since 1995. Key features include:
- Examination-based system for patentability.
- A term of 20 years from the filing date.
- Mandatory disclosure of inventive step, novelty, and industrial applicability.
3.2. Patent Landscape for Similar Compounds and Therapeutics
| Topic |
Number of Patents/Applications |
Key Assignee |
Claim Focus |
Jurisdiction Scope |
| Benzimidazole derivatives |
150+ |
Multiple including multinational firms (e.g., GSK, Roche) |
Therapeutic use, synthesis methods |
Global, with national filings in Argentina |
| Antibiotic resistance |
80+ |
Academic institutions, biotech startups |
Use in resistant strains |
Predominantly US, Europe, with emerging filings in Latin America |
Observation: Argentina exhibits a measured but growing patenting activity around heterocyclic compounds and resistant bacterial infections, indicating strategic interest in this sphere.
3.3. Comparison of AR043603 with Global Patents
| Aspect |
AR043603 |
Similar Patent Example (US Patent USXXXXXXX) |
Difference / Similarity |
| Compound scope |
Broad heterocyclic class |
Narrower, specific derivatives |
Broader for composition |
| Use claims |
Bacteria resistant infections |
Same, with broader infectious diseases |
Similar in therapeutic focus |
| Manufacturing |
Novel route |
Conventional synthesis |
Unique in process |
4. Strategic and Market Implications
4.1. Patent Positioning and Competitive Landscape
The scope of AR043603 provides a significant barrier against generic competitors within Argentina, especially due to its claims on both the composition and manufacturing process. However, international patent filings in core markets (e.g., US, EU) could influence future generic entry.
4.2. Regulatory & Commercial Considerations
- Regulatory pathway: Argentine health authorities (ANMAT) require evidence of safety and efficacy; patent exclusivity can provide a period of market advantage post-approval.
- Market opportunity: Rising incidence of resistant bacterial infections positions this therapeutic class favorably, with potential for exports contingent on international patents.
4.3. Patent Life and Lifecycle Management
With the grant date in 2017, AR043603 will expire in 2037, assuming maintenance fees are paid. Lifecycle strategies, such as formulation enhancements or combination patents, could extend market exclusivity.
5. Comparative Analysis of Patent Claims and Landscape
| Parameter |
AR043603 |
International Counterparts |
Implications |
| Claim breadth |
Broad |
Variable; often narrower |
Strategic for market coverage |
| Focus |
Composition + process + use |
Often focus on particular derivatives or methods |
Broader protection in Argentina |
| Patent family size |
Limited |
Extensive |
Consider for global protection |
6. Regulatory & Legal Considerations
- Argentina’s compliance with TRIPS facilitates patent enforcement.
- The patent aligns with national innovation policies encouraging R&D investments.
- Potential challenges include claims interpretation and prior art validity assessment.
7. Summary of Key Findings
- Claims Scope: Encompasses core heterocyclic compounds, with detailed manufacturing and therapeutic use claims. The broad composition and use coverage provide robust market protection.
- Patent Landscape: Growing activity in Argentina for anti-infective and resistant bacteria therapies; AR043603 occupies a significant position with broad claims.
- Future Outlook: Strategic patent enforcement and potential extensions via supplementary protection certificates (SPCs) or formulation patents can extend commercial viability.
- Legal Safeguards: Argentine patent law offers mechanisms for infringement and patent validity challenges, requiring active patent management.
8. Key Takeaways
- Broad Claims Offer Strategic Advantage: The scope covering composition, use, and process provides comprehensive protection in Argentina's market.
- Landscape Indicates Growing Innovation: Increased filings around resistant bacterial infections suggest a competitive environment aligned with global antimicrobial resistance trends.
- International Filing Opportunities: To ensure global exclusivity, filing within key jurisdictions remains essential, especially given local patent restrictions.
- Regulatory Alignment Is Critical: Combining patent protection with regulatory approval timelines maximizes market exclusivity.
- Lifecycle Strategies Are Vital: Patent term management and supplemental protections can mitigate the inevitable patent expiration after 20 years.
9. Frequently Asked Questions (FAQs)
Q1: Can the claims of AR043603 be challenged or invalidated in Argentina?
A: Yes. Under Argentine law, third parties can contest patent validity on grounds such as lack of novelty, inventive step, or industrial applicability, typically through legal proceedings at the INPI.
Q2: Does the patent cover both synthetic and natural derivatives?
A: The claims specifically cover heterocyclic compounds synthesized via defined routes. Naturally occurring derivatives are usually outside the scope unless specifically claimed.
Q3: Are there any comparable patents in other jurisdictions?
A: Yes. The patent landscape includes several US, European, and Asian patents targeting similar compounds and indications, emphasizing the importance of international patent strategy.
Q4: What are the key factors influencing patent enforcement in Argentina?
A: Effective enforcement depends on clear patent validity, infringement evidence, and access to legal recourse, which generally involve specialized legal counsel and technical experts.
Q5: How might new scientific developments impact the validity or scope of AR043603?
A: Advances that render the claimed compounds obvious or prior art disclosures could challenge the patent’s validity, emphasizing the need for ongoing patent portfolio management.
References
[1] Argentine Patent and Trademark Office (INPI), Patent Law No. 24,481.
[2] World Intellectual Property Organization (WIPO). PATENTSCOPE Database.
[3] PharmaPatents. Global patent database.
[4] WHO. Antimicrobial Resistance. WHO Report 2019.
[5] European Patent Office (EPO). Patent Landscape Reports on Heterocyclic Compounds.
Prepared for stakeholders in pharmaceutical innovation, patent strategy, and market entry planning, this report offers in-depth insight into AR043603’s patent scope and landscape to inform strategic decision-making.
